Effect of Losartan and Amlodipine on Lung Function Status in Hypertensive Patients: A Randomized Control Trial

Authors

  • Mst Nasrin Nahar Assistant Professor of Physiology, AFMC, Dhaka, Bangladesh
  • Shelina Begum Professor and Chairman of Physiology, BSMMU, Shahbag, Dhaka, Bangladesh
  • Sultana Ferdousi Department of Physiology, BSMMU, Shahbag, Dhaka, Bangladesh
  • Tamanna Habib Assistant Professor, Department of Physiology, Anower Khan Modern Medical College and Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/jafmc.v15i1.48640

Keywords:

Hypertensive patients, Lung function test

Abstract

Introduction: Essential hypertension is associated with altered pulmonary function. Antihypertensive medication and lung function are also associated. Losartan (angiotensin II receptor blocker) and amlodipine (calcium channel blocker) are commonly used antihypertensive drugs.

Objectives: To evaluate the effects of antihypertensive drugs on lung function status in patients with essential hypertension.

Materials and Methods: This prospective observational study was carried out in the Department of Physiology of Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, from July 2012 to June 2013 on 100 newly diagnosed hypertensive patients without any antihypertensive medication (group B, age 30-55 years). They were selected from the Out Patient Department (OPD) of Cardiology, BSMMU, Dhaka. Age, sex and BMI matched 50 apparently healthy normotensive subjects were also studied as control (group A). Based on treatment, these study subjects were divided into two groups (B1 and B2). Group B1 included 50 patients received losartan 50 mg daily and B2 included 50 patients received amlodipine 5 mg daily. They were observed once before the treatment (B1a and B2a), after 3 months of medication (B1b and B2b) and after 6 months of medication (B1c and B2c). For assessing lung function status, Forced Vital Capacity (FVC), Forced Expiratory Volume in 1st second (FEV1) and Peak Expiratory Flow Rate (PEFR) were measured with a RMS computer based Spirometer.

Results: Mean FVC, FEV1 and PEFR were significantly lower in newly diagnosed hypertensive patients in comparison with that of healthy normotensive. Mean FVC, FEV1 and PEFR were found significantly higher in the group taking losartan and amlodipine for 6 months when compared to newly diagnosed but lower than those of controls.

Conclusion: Reduced lung function occurs in newly diagnosed hypertensive patients which was improved by treatment with losartan and amlodipine.

Journal of Armed Forces Medical College Bangladesh Vol.15 (1) 2019: 42-44

Downloads

Download data is not yet available.
Abstract
337
PDF
307

Downloads

Published

2020-08-20

How to Cite

Nahar, M. N., Begum, S., Ferdousi, S., & Habib, T. (2020). Effect of Losartan and Amlodipine on Lung Function Status in Hypertensive Patients: A Randomized Control Trial. Journal of Armed Forces Medical College, Bangladesh, 15(1), 42–44. https://doi.org/10.3329/jafmc.v15i1.48640

Issue

Section

Original Papers